New Prostate Guide Sets Risk-Based PSA Tests
New Prostate Guide Sets Risk-Based PSA Tests
New Prostate Guide Sets Risk-Based PSA Tests
Key points
اہم نکات
मुख्य बातें
- The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests.
- Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
- The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests.
- Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
- The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests.
- Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests. Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests. Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
The American Cancer Society has updated its prostate cancer screening guideline, moving to risk-based intervals for PSA tests. Under the new guidance, how often men are screened will depend on their individual risk rather than a one-size-fits-all schedule, in a bid to catch dangerous cancers while cutting needless testing.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।